Comparison of two kinds of hemodialysis filters in controlling serum phosphate

Randomized clinical trial of comparing hemodialysis with high-flux and low-flux filters in controlling hyperphosphatemia in patients with end stage renal disease

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201306136123N2

Enrollment

Registered

2013-06-28

Start date

2012-12-25

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: End stage renal disease treated with dialysis. Condition 2: Instrumentation used in hemodialysis. Chronic kidney disease, stage 5 Preparatory care for dialysis

Interventions

Intervention 1: In low-flux group, patients will be hemodialysed with low-flux filter for two months. Intervention 2: In high-flux group, patients will be hemodialysed with high-flux filter for two mo

Treatment - Devices

In low-flux group, patients will be hemodialysed with low-flux filter for two months

In high-flux group, patients will be hemodialysed with high-flux filter for two months

Eligibility

Sex/Gender

All

Age

10 Years to 85 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age between 10-85 years old; patient is hemodialyzed for at least 6 months. Exclusion criteria: Patients using phosphate binder drugs irregularly; patients who are attending for hemodialysis irregularly.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Serum phosphate level. Timepoint: Before starting the study and two months after hemodialysis. Method of measurement: Laboratory kit.;Hemoglobin. Timepoint: Before starting the study and two months after hemodialysis. Method of measurement: Laboratory kit.;Lipid profile. Timepoint: Before starting the study and two months after hemodialysis. Method of measurement: Laboratory kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHesam Rasoul Amini

University of Medical Sciences

hesam_a6@yahoo.com+41 13341317

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026